デュシェンヌ型筋ジストロフィー（DMD）治療の世界市場 2023-2027

デュシェンヌ型筋ジストロフィー（DMD）治療市場2023-2027

デュシェンヌ型筋ジストロフィー（DMD）治療市場は、2022-2027年にCAGR 21.2％で23億9,767万米ドルの成長が予測されています。当レポートでは、デュシェンヌ型筋ジストロフィー（DMD）治療市場の全体的な分析、市場規模・予測、動向、市場促進要因・促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、デュシェンヌ型筋ジストロフィー（DMD）患者のアンメットニーズの高さ、市場ベンダー間の戦略的提携の増加、患者支援プログラムの利用可能性などが牽引しています。

本調査では、デュシェンヌ型筋ジストロフィー（DMD）治療の強力なパイプラインが、今後数年間のデュシェンヌ型筋ジストロフィー（DMD）治療市場の成長を促進する主要な理由の一つであると指摘しています。また、デュシェンヌ型筋ジストロフィー（DMD）に対する研究資金の増加やデュシェンヌ型筋ジストロフィー（DMD）治療の特効薬指定は、市場の大きな需要につながると思われます。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2022
• 市場の見通し 2022-2027

第4章 市場規模実績

• デュシェンヌ型筋ジストロフィー（DMD）治療の世界市場 2017-2021
• タイプ別セグメント分析 2017-2021
• 流通チャネル別セグメント分析 2017-2021
• 地域別セグメント分析 2017-2021
• 国別セグメント分析 2017-2021

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：タイプ別

• 市場セグメント
• 比較：タイプ別
• 生物学的製剤：市場規模と予測 2022-2027
• 低分子：市場規模と予測 2022-2027
• 市場機会：タイプ別

第7章 市場セグメンテーション：流通チャネル別

• 市場セグメント
• 比較：流通チャネル別
• オフライン：市場規模と予測 2022-2027
• オンライン：市場規模と予測 2022-2027
• 市場機会：流通チャネル別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2022-2027
• 欧州：市場規模と予測 2022-2027
• アジア：市場規模と予測 2022-2027
• 世界のその他の地域：市場規模と予測 2022-2027
• 米国：市場規模と予測 2022-2027
• ドイツ：市場規模と予測 2022-2027
• 英国：市場規模と予測 2022-2027
• カナダ：市場規模と予測 2022-2027
• 中国：市場規模と予測 2022-2027
• 市場機会：地域情勢別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• Capricor Therapeutics Inc.
• CRISPR Therapeutics AG
• Daiichi Sankyo Co. Ltd.
• Editas Medicine Inc.
• F. Hoffmann La Roche Ltd.
• Italfarmaco Holding SPA
• Nippon Shinyaku Co. Ltd.
• Otsuka Holdings Co. Ltd.
• Pfizer Inc.
• PTC Therapeutics Inc.
• Santhera Pharmaceuticals Holding AG
• Sarepta Therapeutics Inc
• Solid Biosciences Inc.
• The Cleveland Clinic Foundation
• Wave Life Sciences Ltd.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Type
• Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on global duchenne muscular dystrophy (dmd) therapeutics market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Type - Market share 2022-2027 (%)
• Exhibits31: Data Table on Type - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Type
• Exhibits33: Data Table on Comparison by Type
• Exhibits34: Chart on Biologics - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Biologics - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Biologics - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Biologics - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Small molecules - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Small molecules - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Small molecules - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Small molecules - Year-over-year growth 2022-2027 (%)
• Exhibits42: Market opportunity by Type ($ million)
• Exhibits43: Data Table on Market opportunity by Type ($ million)
• Exhibits44: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibits45: Data Table on Distribution Channel - Market share 2022-2027 (%)
• Exhibits46: Chart on Comparison by Distribution Channel
• Exhibits47: Data Table on Comparison by Distribution Channel
• Exhibits48: Chart on Offline - Market size and forecast 2022-2027 ($ million)
• Exhibits49: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
• Exhibits50: Chart on Offline - Year-over-year growth 2022-2027 (%)
• Exhibits51: Data Table on Offline - Year-over-year growth 2022-2027 (%)
• Exhibits52: Chart on Online - Market size and forecast 2022-2027 ($ million)
• Exhibits53: Data Table on Online - Market size and forecast 2022-2027 ($ million)
• Exhibits54: Chart on Online - Year-over-year growth 2022-2027 (%)
• Exhibits55: Data Table on Online - Year-over-year growth 2022-2027 (%)
• Exhibits56: Market opportunity by Distribution Channel ($ million)
• Exhibits57: Data Table on Market opportunity by Distribution Channel ($ million)
• Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits61: Chart on Geographic comparison
• Exhibits62: Data Table on Geographic comparison
• Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits85: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits87: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibits89: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits90: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits91: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits92: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits93: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits94: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits95: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibits96: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibits97: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits98: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits99: Market opportunity By Geographical Landscape ($ million)
• Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits101: Impact of drivers and challenges in 2022 and 2027
• Exhibits102: Overview on Criticality of inputs and Factors of differentiation
• Exhibits103: Overview on factors of disruption
• Exhibits104: Impact of key risks on business
• Exhibits105: Vendors covered
• Exhibits106: Matrix on vendor position and classification
• Exhibits107: Capricor Therapeutics Inc. - Overview
• Exhibits108: Capricor Therapeutics Inc. - Product / Service
• Exhibits109: Capricor Therapeutics Inc. - Key offerings
• Exhibits110: CRISPR Therapeutics AG - Overview
• Exhibits111: CRISPR Therapeutics AG - Product / Service
• Exhibits112: CRISPR Therapeutics AG - Key offerings
• Exhibits113: Daiichi Sankyo Co. Ltd. - Overview
• Exhibits114: Daiichi Sankyo Co. Ltd. - Product / Service
• Exhibits115: Daiichi Sankyo Co. Ltd. - Key news
• Exhibits116: Daiichi Sankyo Co. Ltd. - Key offerings
• Exhibits117: Editas Medicine Inc. - Overview
• Exhibits118: Editas Medicine Inc. - Product / Service
• Exhibits119: Editas Medicine Inc. - Key offerings
• Exhibits120: F. Hoffmann La Roche Ltd. - Overview
• Exhibits121: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits122: F. Hoffmann La Roche Ltd. - Key news
• Exhibits123: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits124: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits125: Italfarmaco Holding SPA - Overview
• Exhibits126: Italfarmaco Holding SPA - Product / Service
• Exhibits127: Italfarmaco Holding SPA - Key offerings
• Exhibits128: Nippon Shinyaku Co. Ltd. - Overview
• Exhibits129: Nippon Shinyaku Co. Ltd. - Business segments
• Exhibits130: Nippon Shinyaku Co. Ltd. - Key offerings
• Exhibits131: Nippon Shinyaku Co. Ltd. - Segment focus
• Exhibits132: Otsuka Holdings Co. Ltd. - Overview
• Exhibits133: Otsuka Holdings Co. Ltd. - Business segments
• Exhibits134: Otsuka Holdings Co. Ltd. - Key offerings
• Exhibits135: Otsuka Holdings Co. Ltd. - Segment focus
• Exhibits136: Pfizer Inc. - Overview
• Exhibits137: Pfizer Inc. - Product / Service
• Exhibits138: Pfizer Inc. - Key news
• Exhibits139: Pfizer Inc. - Key offerings
• Exhibits140: PTC Therapeutics Inc. - Overview
• Exhibits141: PTC Therapeutics Inc. - Product / Service
• Exhibits142: PTC Therapeutics Inc. - Key offerings
• Exhibits143: Santhera Pharmaceuticals Holding AG - Overview
• Exhibits144: Santhera Pharmaceuticals Holding AG - Product / Service
• Exhibits145: Santhera Pharmaceuticals Holding AG - Key offerings
• Exhibits146: Sarepta Therapeutics Inc - Overview
• Exhibits147: Sarepta Therapeutics Inc - Product / Service
• Exhibits148: Sarepta Therapeutics Inc - Key offerings
• Exhibits149: Solid Biosciences Inc. - Overview
• Exhibits150: Solid Biosciences Inc. - Product / Service
• Exhibits151: Solid Biosciences Inc. - Key offerings
• Exhibits152: The Cleveland Clinic Foundation - Overview
• Exhibits153: The Cleveland Clinic Foundation - Product / Service
• Exhibits154: The Cleveland Clinic Foundation - Key offerings
• Exhibits155: Wave Life Sciences Ltd. - Overview
• Exhibits156: Wave Life Sciences Ltd. - Product / Service
• Exhibits157: Wave Life Sciences Ltd. - Key offerings
• Exhibits158: Inclusions checklist
• Exhibits159: Exclusions checklist
• Exhibits160: Currency conversion rates for US$
• Exhibits161: Research methodology
• Exhibits162: Validation techniques employed for market sizing
• Exhibits163: Information sources
• Exhibits164: List of abbreviations

Duchenne Muscular Dystrophy (DMD) Therapeutics Market 2023-2027

The Duchenne muscular dystrophy (DMD) therapeutics market is forecasted to grow by USD 2,397.67 mn during 2022-2027, accelerating at a CAGR of 21.2% during the forecast period. The report on the Duchenne muscular dystrophy (DMD) therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high unmet need among patients with Duchenne muscular dystrophy (DMD), increasing strategic alliances among market vendors, and availability of patient assistance programs.

Technavio's Duchenne muscular dystrophy (DMD) therapeutics market is segmented as below:

By Type

• Biologics
• Small molecules

By Distribution Channel

• Offline
• Online

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the strong pipeline of Duchenne muscular dystrophy (DMD) therapeutics as one of the prime reasons driving the Duchenne muscular dystrophy (DMD) therapeutics market growth during the next few years. Also, increasing research funding for Duchenne muscular dystrophy (DMD) and special drug designation for Duchenne muscular dystrophy (DMD) therapeutics will lead to sizable demand in the market.

The report on the Duchenne muscular dystrophy (DMD) therapeutics market covers the following areas:

• Duchenne muscular dystrophy (DMD) therapeutics market sizing
• Duchenne muscular dystrophy (DMD) therapeutics market forecast
• Duchenne muscular dystrophy (DMD) therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading Duchenne muscular dystrophy (DMD) therapeutics market vendors that include BioMarin Pharmaceutical Inc., Capricor Therapeutics Inc., CRISPR Therapeutics AG, CVS Health Corp., Daiichi Sankyo Co. Ltd., Editas Medicine Inc., Eli Lilly and Co., F. Hoffmann La Roche Ltd., FibroGen Inc., Italfarmaco Holding SPA, Nippon Shinyaku Co. Ltd., Otsuka Holdings Co. Ltd., Pfizer Inc., PTC Therapeutics Inc., Santhera Pharmaceuticals Holding AG, Sarepta Therapeutics Inc, Solid Biosciences Inc., The Cleveland Clinic Foundation, Vertex Pharmaceuticals Inc., and Wave Life Sciences Ltd. Also, the Duchenne muscular dystrophy (DMD) therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global duchenne muscular dystrophy (DMD) therapeutics market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on global duchenne muscular dystrophy (dmd) therapeutics market 2017 - 2021 ($ million)
• 4.2 Type Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
• 4.3 Distribution Channel Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

• 6.1 Market segments
• Exhibit 30: Chart on Type - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
• 6.2 Comparison by Type
• Exhibit 32: Chart on Comparison by Type
• Exhibit 33: Data Table on Comparison by Type
• 6.3 Biologics - Market size and forecast 2022-2027
• Exhibit 34: Chart on Biologics - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Biologics - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Biologics - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Biologics - Year-over-year growth 2022-2027 (%)
• 6.4 Small molecules - Market size and forecast 2022-2027
• Exhibit 38: Chart on Small molecules - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Small molecules - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Small molecules - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Small molecules - Year-over-year growth 2022-2027 (%)
• 6.5 Market opportunity by Type
• Exhibit 42: Market opportunity by Type ($ million)
• Exhibit 43: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Distribution Channel

• 7.1 Market segments
• Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
• Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
• 7.2 Comparison by Distribution Channel
• Exhibit 46: Chart on Comparison by Distribution Channel
• Exhibit 47: Data Table on Comparison by Distribution Channel
• 7.3 Offline - Market size and forecast 2022-2027
• Exhibit 48: Chart on Offline - Market size and forecast 2022-2027 ($ million)
• Exhibit 49: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
• Exhibit 50: Chart on Offline - Year-over-year growth 2022-2027 (%)
• Exhibit 51: Data Table on Offline - Year-over-year growth 2022-2027 (%)
• 7.4 Online - Market size and forecast 2022-2027
• Exhibit 52: Chart on Online - Market size and forecast 2022-2027 ($ million)
• Exhibit 53: Data Table on Online - Market size and forecast 2022-2027 ($ million)
• Exhibit 54: Chart on Online - Year-over-year growth 2022-2027 (%)
• Exhibit 55: Data Table on Online - Year-over-year growth 2022-2027 (%)
• 7.5 Market opportunity by Distribution Channel
• Exhibit 56: Market opportunity by Distribution Channel ($ million)
• Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 61: Chart on Geographic comparison
• Exhibit 62: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 Germany - Market size and forecast 2022-2027
• Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.9 UK - Market size and forecast 2022-2027
• Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.10 Canada - Market size and forecast 2022-2027
• Exhibit 91: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.11 China - Market size and forecast 2022-2027
• Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 99: Market opportunity By Geographical Landscape ($ million)
• Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 101: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 103: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 104: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 105: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 106: Matrix on vendor position and classification
• 12.3 Capricor Therapeutics Inc.
• Exhibit 107: Capricor Therapeutics Inc. - Overview
• Exhibit 108: Capricor Therapeutics Inc. - Product / Service
• Exhibit 109: Capricor Therapeutics Inc. - Key offerings
• 12.4 CRISPR Therapeutics AG
• Exhibit 110: CRISPR Therapeutics AG - Overview
• Exhibit 111: CRISPR Therapeutics AG - Product / Service
• Exhibit 112: CRISPR Therapeutics AG - Key offerings
• 12.5 Daiichi Sankyo Co. Ltd.
• Exhibit 113: Daiichi Sankyo Co. Ltd. - Overview
• Exhibit 114: Daiichi Sankyo Co. Ltd. - Product / Service
• Exhibit 115: Daiichi Sankyo Co. Ltd. - Key news
• Exhibit 116: Daiichi Sankyo Co. Ltd. - Key offerings
• 12.6 Editas Medicine Inc.
• Exhibit 117: Editas Medicine Inc. - Overview
• Exhibit 118: Editas Medicine Inc. - Product / Service
• Exhibit 119: Editas Medicine Inc. - Key offerings
• 12.7 F. Hoffmann La Roche Ltd.
• Exhibit 120: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 121: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 122: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 123: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 124: F. Hoffmann La Roche Ltd. - Segment focus
• 12.8 Italfarmaco Holding SPA
• Exhibit 125: Italfarmaco Holding SPA - Overview
• Exhibit 126: Italfarmaco Holding SPA - Product / Service
• Exhibit 127: Italfarmaco Holding SPA - Key offerings
• 12.9 Nippon Shinyaku Co. Ltd.
• Exhibit 128: Nippon Shinyaku Co. Ltd. - Overview
• Exhibit 129: Nippon Shinyaku Co. Ltd. - Business segments
• Exhibit 130: Nippon Shinyaku Co. Ltd. - Key offerings
• Exhibit 131: Nippon Shinyaku Co. Ltd. - Segment focus
• 12.10 Otsuka Holdings Co. Ltd.
• Exhibit 132: Otsuka Holdings Co. Ltd. - Overview
• Exhibit 133: Otsuka Holdings Co. Ltd. - Business segments
• Exhibit 134: Otsuka Holdings Co. Ltd. - Key offerings
• Exhibit 135: Otsuka Holdings Co. Ltd. - Segment focus
• 12.11 Pfizer Inc.
• Exhibit 136: Pfizer Inc. - Overview
• Exhibit 137: Pfizer Inc. - Product / Service
• Exhibit 138: Pfizer Inc. - Key news
• Exhibit 139: Pfizer Inc. - Key offerings
• 12.12 PTC Therapeutics Inc.
• Exhibit 140: PTC Therapeutics Inc. - Overview
• Exhibit 141: PTC Therapeutics Inc. - Product / Service
• Exhibit 142: PTC Therapeutics Inc. - Key offerings
• 12.13 Santhera Pharmaceuticals Holding AG
• Exhibit 143: Santhera Pharmaceuticals Holding AG - Overview
• Exhibit 144: Santhera Pharmaceuticals Holding AG - Product / Service
• Exhibit 145: Santhera Pharmaceuticals Holding AG - Key offerings
• 12.14 Sarepta Therapeutics Inc
• Exhibit 146: Sarepta Therapeutics Inc - Overview
• Exhibit 147: Sarepta Therapeutics Inc - Product / Service
• Exhibit 148: Sarepta Therapeutics Inc - Key offerings
• 12.15 Solid Biosciences Inc.
• Exhibit 149: Solid Biosciences Inc. - Overview
• Exhibit 150: Solid Biosciences Inc. - Product / Service
• Exhibit 151: Solid Biosciences Inc. - Key offerings
• 12.16 The Cleveland Clinic Foundation
• Exhibit 152: The Cleveland Clinic Foundation - Overview
• Exhibit 153: The Cleveland Clinic Foundation - Product / Service
• Exhibit 154: The Cleveland Clinic Foundation - Key offerings
• 12.17 Wave Life Sciences Ltd.
• Exhibit 155: Wave Life Sciences Ltd. - Overview
• Exhibit 156: Wave Life Sciences Ltd. - Product / Service
• Exhibit 157: Wave Life Sciences Ltd. - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 158: Inclusions checklist
• Exhibit 159: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 160: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 161: Research methodology
• Exhibit 162: Validation techniques employed for market sizing
• Exhibit 163: Information sources
• 13.5 List of abbreviations
• Exhibit 164: List of abbreviations